Neoplasms

Skin and Connective Tissue Diseases

All Conditions

Blood and Lymph Conditions

Behaviors and Mental Disorders

Rare Diseases

Breast Neoplasms

Anemia

Red-Cell Aplasia, Pure

Breast Diseases

Skin Diseases

Quality of Life

Pure Red Cell Aplasia

Anti-Inflammatory Agents

Antirheumatic Agents

Analgesics

All Drugs and Chemicals

Hematinics

Chrysarobin

Epoetin Alfa

epoetin alfa

Ortho Biotech Products, L.P. Clinical Trial

The purpose of this study is to determine whether it is possible to measure temporary difficulty with thinking and/or short-term memory in women who are receiving chemotherapy for early stage breast cancer and to determine whether or not treatment with PROCRITÂ® will help decrease any problems with thinking or short-term memory that chemotherapy may cause.

Studies of the effect of erythropoietin on rat and mouse brain suggests a neuroprotective and cognitive-enhancing effect of this hormone. The objective of this study was to quantify and compare the incidence of chemotherapy-related impairment of cognitive and executive function in breast cancer patients randomized to receive PROCRIT versus placebo while receiving adjuvant anthracycline-based chemotherapy with or without a Taxane and to evaluate the effect of PROCRIT® on the incidence of asthenia (severe fatigue), quality of life (QoL), and mood. Patients received study medication injections (40,000 units) under their skin once every week for 12 to 24 weeks of chemotherapy. Doses were adjusted depending on the patients' hemoglobin level up to a maximum of 60,000 units.

A Phase III Clinical Trial of PROCRIT (Epoetin Alfa) Versus Placebo in Women Undergoing Adjuvant Chemotherapy for Stage I, II or III Breast Cancer

Ortho Biotech Products, L.P.

Effect of exercise training on breast cancer patient

twelve-week aerobic exercise training program consisted of three sessions per week, each session lasting 30 to 60 minutes 50 to 75 percent of their maximum heart rate reserve

Exercise training

Introduction: The purpose of this study was to determine the effect of twelve weeks of aerobic exercise program on erythrocyte levels in women with breast cancer after chemotherapy.

Methods: Thirty women with breast cancer after chemotherapy of Sydalshhda hospital (aged between 47-65 years) volunteered for this study, and then randomly selected an exercise (n = 15) and control (n = 15) groups. Exercise group completed a twelve-week aerobic exercise training program consisted of three sessions per week, each session lasting 30 to 60 minutes 50 to 75 percent of their maximum heart rate reserve, while the control group were followed. Blood samples including red blood cell counts (RBC), hematocrit (HCT), hemoglobin (HB), peak oxygen consumption before and after 12 weeks of aerobic exercise were measured. For analysis of data, repeated-measures analysis of variance (ANOVA) was used.

Effect Aerobic Training on Women With Breast Cancer After Chemotherapy

The Effect of 12 Weeks of Aerobic Training Program on Erythrocyte Levels in Women With Breast Cancer After Chemotherapy

University of Isfahan

Principal Investigator

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
A Phase III Clinical Trial of PROCRIT (Epoetin Alfa) Versus Placebo in Women Undergoing Adjuvant Chemotherapy for Stage I, II or III Breast Cancer	NCT00246597	Anemia Breast Neoplasm... Hemoglobins Quality of Life Chemotherapy, A...	epoetin alfa	18 Years -	Ortho Biotech Products, L.P.
A Phase III Clinical Trial of PROCRIT (Epoetin Alfa) Versus Placebo in Women Undergoing Adjuvant Chemotherapy for Stage I, II or III Breast Cancer	NCT00246597	Anemia Breast Neoplasm... Hemoglobins Quality of Life Chemotherapy, A...	epoetin alfa	18 Years -	Ortho Biotech Products, L.P.
Effect Aerobic Training on Women With Breast Cancer After Chemotherapy	NCT02876627	Cancer Exercise Hemoglobins	Exercise traini...	47 Years - 65 Years	University of Isfahan

Spots Global Cancer Trial Database for hemoglobins

Every month we try and update this database with for hemoglobins cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

Spots Global Cancer Trial Database for hemoglobins

Every month we try and update this database with for hemoglobins cancer trials from around the world to help patients and their families find trials that might be right for them. We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

Every month we try and update this database with for hemoglobins cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.